GoHealth (NASDAQ:GOCO) Stock Rating Lowered by Freedom Capital

GoHealth (NASDAQ:GOCOGet Free Report) was downgraded by equities researchers at Freedom Capital from a “strong-buy” rating to a “hold” rating in a note issued to investors on Monday,Zacks.com reports.

A number of other analysts have also recently commented on GOCO. Noble Financial raised GoHealth to a “strong-buy” rating in a research report on Wednesday, April 1st. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of GoHealth in a research report on Monday, December 29th. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $5.00.

View Our Latest Stock Analysis on GoHealth

GoHealth Stock Performance

GoHealth stock opened at $1.16 on Monday. The stock’s 50 day simple moving average is $1.69 and its two-hundred day simple moving average is $2.71. The stock has a market cap of $33.30 million, a price-to-earnings ratio of -0.06 and a beta of 1.61. GoHealth has a fifty-two week low of $1.12 and a fifty-two week high of $11.36.

GoHealth (NASDAQ:GOCOGet Free Report) last posted its quarterly earnings data on Tuesday, March 31st. The company reported ($1.03) earnings per share for the quarter, beating the consensus estimate of ($2.69) by $1.66. The business had revenue of $12.64 million for the quarter, compared to analysts’ expectations of $88.62 million. GoHealth had a positive return on equity of 8.00% and a negative net margin of 26.95%. On average, analysts predict that GoHealth will post -5.5 earnings per share for the current year.

Institutional Investors Weigh In On GoHealth

A number of hedge funds have recently added to or reduced their stakes in GOCO. Public Sector Pension Investment Board bought a new position in GoHealth in the 3rd quarter worth $8,100,000. Redwood Capital Management LLC bought a new stake in GoHealth in the 3rd quarter worth approximately $4,455,000. Focus Partners Wealth bought a new stake in GoHealth in the 3rd quarter worth approximately $270,000. Deutsche Bank AG increased its stake in GoHealth by 150.8% in the 4th quarter. Deutsche Bank AG now owns 32,183 shares of the company’s stock worth $69,000 after acquiring an additional 19,349 shares during the last quarter. Finally, Jane Street Group LLC bought a new stake in GoHealth in the 1st quarter worth approximately $177,000. 24.21% of the stock is currently owned by hedge funds and other institutional investors.

More GoHealth News

Here are the key news stories impacting GoHealth this week:

  • Positive Sentiment: Sidoti raised multiple near-term estimates and trimmed expected losses — the firm boosted Q1–Q3 2026 and several 2027 quarter forecasts and cut its Q3 2026 loss estimate sharply (from ($3.30) to ($1.47)), and also narrowed FY2026 and FY2027 losses, signaling improving margin expectations.
  • Positive Sentiment: Noble Financial lifted its FY2027 EPS view materially to a positive $1.93 and retains a “Strong‑Buy” stance, implying at least one analyst expects a recovery into positive earnings by 2027.
  • Neutral Sentiment: Sidoti published a full schedule of quarter-by-quarter EPS projections (Q1–Q4 2026/2027 and FY figures), providing updated modeling inputs for investors but not changing consensus direction on current-year losses.
  • Negative Sentiment: Noble trimmed its FY2026 view to ($8.55) from ($7.53), increasing near-term expected losses and adding uncertainty to the recovery timeline.
  • Negative Sentiment: Freedom Capital downgraded GoHealth from “Strong‑Buy” to “Hold,” a near-term negative for sentiment among retail/small institutional holders. Freedom Capital downgrade
  • Negative Sentiment: Fundamentals remain weak: recent quarterly results showed a very large revenue shortfall and continued negative EPS and margins; market cap is small and the company sits near its 52‑week low, making the stock sensitive to analyst sentiment and liquidity.

GoHealth Company Profile

(Get Free Report)

GoHealth, Inc is a technology-driven health insurance marketplace that connects consumers with a wide range of health insurance plans from leading carriers. Through its digital platform, the company facilitates the comparison, selection and enrollment process for individual and family plans, as well as Medicare Advantage and Medicare Supplement products. By leveraging data analytics and customer support services, GoHealth aims to simplify a traditionally complex market and enable more informed decision-making for policyholders.

The company’s online portal integrates real-time quoting tools, educational resources and access to licensed insurance agents, ensuring that users receive personalized guidance throughout the enrollment journey.

Featured Articles

Analyst Recommendations for GoHealth (NASDAQ:GOCO)

Receive News & Ratings for GoHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GoHealth and related companies with MarketBeat.com's FREE daily email newsletter.